7 January 2021
To address this worldwide public health crisis, Access Consortium members are collaborating to advance the regulatory science needed to support the rapid development of diagnostic tests, as well as vaccines and treatments against COVID-19. Members are committed to sharing vital information as we all investigate and evaluate medical products for quality, safety and efficacy, and strive to ensure that the benefits of any new medical product outweigh its risks.
During these unprecedented times, the Consortium is building on its proven ability to benefit from work-sharing that has recently led to the approval of numerous medicines. Consortium members remain committed to review and collaborate on COVID-19 vaccine candidates and treatment options, with the goal of expediting their review and availability on the market. Through this partnership, Access will reduce regulatory duplication and increase each agency’s capacity to ensure that, globally, there is access to high-
Sunday, 03 Jan 2021 08:22 AM MYT
Nervotec founder Jonathan Lau with his firm’s Awareness mobile application, which can measure a user’s heart rate and oxygen saturation with just a front-facing camera. TODAY pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
SINGAPORE, Jan 3 Hold your phone to your face for about a minute and it would be able to tell your heart rate, oxygen saturation, respiration rate and stress level with medical grade accuracy.
That is what Singapore health startup Nervotec is promising with its application, which detects a user’s vital signs by studying the way light reflects off a user’s face changes as blood flows through the capillaries under the skin.
Healthcare Asia Daily News | Asia s Leading News and Information Source on Healthcare and Medical Industry, Medical Technology, Healthcare Business and R&D, Healthcare Events. Online since 2010.